Consistently, it was found that in different ccRCC cell lines, the activation of mTOR promotes the expression of E3 ubiquitin-protein MDM2, which, in turn, induces p53 ubiquitination and degradation by proteasome [34]. Here, MDM2 is linked to nonpapillary renal cell carcinoma.